• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Wave Life Sciences Ltd. - Ordinary Shares (NQ:WVE)

    6.365 +0.005 (+0.08%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Mar 27, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 14,768
    Open 6.365
    Bid (Size) 6.380 (2,100)
    Ask (Size) 6.420 (300)
    Prev. Close 6.360
    Today's Range 6.365 - 6.365
    52wk Range 5.020 - 21.73
    Shares Outstanding 98,983,261
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Stock Market Today, March 26: Wave Life Sciences Plunges After High Dose Obesity Drug Data Disappoints ↗
    On March 26, 2026, traders mulled Wave's weak high-dose obesity results against the company's large market opportunity. 
    Via The Motley Fool
    Topics Stocks
    Top movers analysis one hour before the close of the markets on 2026-03-26: top gainers and losers in today's session. ↗
    Via Chartmill

    Performance

    YTD
    -60.1%
    -60.1%
    1 Month
    -54.0%
    -54.0%
    3 Month
    -64.4%
    -64.4%
    6 Month
    -10.7%
    -10.7%
    1 Year
    -21.2%
    -21.2%

    More News

    Read More
    Here are the top movers in Thursday's session. ↗
    Via Chartmill
    Thursday's session: gap up and gap down stocks ↗
    Via Chartmill
    Wave Life Sciences Ltd (NASDAQ:WVE) Reports Mixed Q4 2025 Results, Highlights Extended Cash Runway to 2028 ↗
    Via Chartmill
    News headline image
    Wave Life Sciences Shakes Biotech Sector with Breakthrough Obesity Data: A New Era for ‘Quality’ Weight Loss
    Via MarketMinute
    These stocks that are showing activity before the opening bell on Thursday. ↗
    Via Chartmill
    News headline image
    Wave Life Sciences Announces Positive Interim Phase 1 Data from INLIGHT: Further Improvements in Body Composition, with Clinically Meaningful Reductions in Visceral Fat and Waist Circumference, at Six Months Following Single Dose of WVE-007
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire
    News headline image
    Wave Life Sciences Announces Acceptance of Late-Breaking Oral Presentation on WVE-006 for Alpha-1 Antitrypsin Deficiency at the American Thoracic Society International Conference
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire
    News headline image
    Wave Life Sciences (WVE) Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Wave Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire
    News headline image
    Wave Life Sciences to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire
    News headline image
    Wave Life Sciences Fourth Quarter and Full Year 2025 Financial Results Scheduled for February 26, 2026
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire
    News headline image
    Drug-Delivery Breakthroughs, Cross-Indication Research Accelerate New Momentum in CNS and Oncology Development
    From BioMedWire
    Via GlobeNewswire
    News headline image
    Wave Life Sciences Announces Plans to Accelerate Regulatory Engagement with Full Control of WVE-006 for Alpha-1 Antitrypsin Deficiency
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire
    News headline image
    This Director Sold 42,000 Shares of Wave Life Sciences for $630,000. What Investors Should Know About This Biotech Company. ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Wave Life Sciences Highlights Strategic Priorities for 2026 at the 44th Annual J.P. Morgan Healthcare Conference: Accelerating Development of WVE-007 (INHBE siRNA) for Obesity and Rapidly Advancing RNA Editing Portfolio
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire
    Stay updated with the stocks that are on the move in today's pre-market session. ↗
    Via Chartmill
    News headline image
    Wave Life Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire
    News headline image
    In today's session, these stocks are experiencing unusual volume. ↗
    Via Chartmill
    News headline image
    Golden Cross Alert: 3 Stocks With Major Upside Potential ↗
    Via MarketBeat
    News headline image
    Wave Life Sciences Prices Upsized $350 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire
    News headline image
    Why Wave Life Sciences Stock Crushed it Again Today ↗
    Via The Motley Fool
    News headline image
    Which stocks have an unusual volume on Tuesday? ↗
    Via Chartmill
    News headline image
    ENDRA Life Sciences (NASDAQ: NDRA) Advances TAEUS® Liver Imaging, Strengthens Capital Efficiency; WVE, TWG, BDRX, FULC Also Active
    Via AB Newswire

    Frequently Asked Questions

    Is Wave Life Sciences Ltd. - Ordinary Shares publicly traded?
    Yes, Wave Life Sciences Ltd. - Ordinary Shares is publicly traded.
    What exchange does Wave Life Sciences Ltd. - Ordinary Shares trade on?
    Wave Life Sciences Ltd. - Ordinary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Wave Life Sciences Ltd. - Ordinary Shares?
    The ticker symbol for Wave Life Sciences Ltd. - Ordinary Shares is WVE on the Nasdaq Stock Market
    What is the current price of Wave Life Sciences Ltd. - Ordinary Shares?
    The current price of Wave Life Sciences Ltd. - Ordinary Shares is 6.365
    When was Wave Life Sciences Ltd. - Ordinary Shares last traded?
    The last trade of Wave Life Sciences Ltd. - Ordinary Shares was at 03/27/26 04:00 PM ET
    What is the market capitalization of Wave Life Sciences Ltd. - Ordinary Shares?
    The market capitalization of Wave Life Sciences Ltd. - Ordinary Shares is 630.03M
    How many shares of Wave Life Sciences Ltd. - Ordinary Shares are outstanding?
    Wave Life Sciences Ltd. - Ordinary Shares has 630M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.